Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefan Faderl
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Adult Acute Lymphoblastic Leukemia
Cancer
Cancer Research
Oncology
Imatinib Front-Line Therapy Is Safe and Effective in Patients With Chronic Myelogenous Leukemia With Pre-Existing Liver and/or Renal Dysfunction
Cancer
Cancer Research
Oncology
Patient-Driven Discontinuation of Tyrosine Kinase Inhibitors: Single Institution Experience
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Phase I Trial of SAR103168, a Novel Multi-Kinase Inhibitor, in Patients With Refractory/Relapsed Acute Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Expectations of Serious Adverse Events at the End of Life of Patients With Acute Myeloid Leukemia Who Receive Salvage Therapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
1
2
›